Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Multinational, Natural History Study in Participants With Congenital Myasthenic Syndromes Due to Mutations in DOK7, MUSK, AGRN, or LRP4

NCT06078553 is registered in ClinicalTrials.gov with argenx as lead sponsor.

NCT NCT06078553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Multinational, Natural History Study in Participants With Congenital Myasthenic Syndromes Due to Mutations in DOK7, MUSK, AGRN, or LRP4
Lead sponsor
argenx
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2024
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

congenital myasthenic syndrome